These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 6605393
21. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae. Gootz TD, Sanders CC, Goering RV. J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593 [Abstract] [Full Text] [Related]
22. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae. Yang YJ, Livermore DM, Williams RJ. J Med Microbiol; 1988 Mar; 25(3):227-33. PubMed ID: 3258037 [Abstract] [Full Text] [Related]
23. [Clinical and laboratory significance of inducible beta-lactamases]. Bedenić B, Zagar Z. Lijec Vjesn; 1995 Mar; 117(9-10):249-53. PubMed ID: 8643019 [Abstract] [Full Text] [Related]
24. Use of chromatofocusing for separation of beta-lactamases. V. Inducible chromosomally mediated beta-lactamase of the Enterobacter cloacae 53 strain. Gál S, Frommer-Filep M, Toth-Martinez BL, Hernádi FJ, Kiss L. J Chromatogr; 1985 Sep 27; 333(1):239-43. PubMed ID: 3877734 [No Abstract] [Full Text] [Related]
25. Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter. Steffee CH, Wasilauskas BL. Chemotherapy; 1992 Sep 27; 38(5):291-6. PubMed ID: 1286572 [Abstract] [Full Text] [Related]
26. The effect of casein derivatives on glycine enhancement of beta-lactamase production in Enterobacter cloacae ATCC.13047. Gatus BJ, Bell SM, Jimenez AS. Pathology; 1986 Oct 27; 18(4):379-81. PubMed ID: 3493468 [Abstract] [Full Text] [Related]
27. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae. Cullmann W, Flensberg T, Opferkuch W, Stieglitz M, Wiedemann B. Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep 27; 252(4):480-9. PubMed ID: 6758422 [Abstract] [Full Text] [Related]
28. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections. Quinn JP, DiVincenzo CA, Foster J. J Infect Dis; 1987 May 27; 155(5):942-7. PubMed ID: 3549922 [Abstract] [Full Text] [Related]
29. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins. Jarlier V, Nicolas MH, Philippon A, Giroir AM, Grosset J. J Antimicrob Chemother; 1989 Aug 27; 24(2):165-72. PubMed ID: 2676939 [Abstract] [Full Text] [Related]
36. The interaction of beta-lactam compounds with chromosomally mediated enzymes: relations to the molecular structure. Cullmann W. Chemotherapy; 1985 Aug 27; 31(4):272-8. PubMed ID: 3875455 [Abstract] [Full Text] [Related]
39. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics. Ramadan MA, Tawfik AF, Shibl AM. Chemotherapy; 1995 Aug 27; 41(3):193-9. PubMed ID: 7656665 [Abstract] [Full Text] [Related]
40. Biochemical characterization of type A and type B beta-lactamase from Enterobacter cloacae. Then RL, Charnas RL, Kocher HP, Manneberg M, Röthlisberger U, Stocker J. Rev Infect Dis; 1988 Aug 27; 10(4):714-20. PubMed ID: 3263683 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]